← Leaderboards
Payam Nahid
University Of California, San Francisco
$19,473,523
Attributed
$48,171,050
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.2M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,044,854 · 12
By mechanism
U01$26,304,816 · 2
R01$17,142,898 · 3
P30$4,975,184 · 4
R25$2,404,075 · 1
K23$625,860 · 1
R43$592,021 · 1
Top collaborators
- Adithya Cattamanchi14 shared
- Claudia Maria Denkinger14 shared
- Elizabeth Fair7 shared
- C Robert Horsburgh7 shared
- John Lucian Davis6 shared
- Gary K Schoolnik6 shared
- George B Sigal5 shared
- Jeffery S Cox4 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Carina Marquez$5,688,493
- Robert J Blount$890,522
- Judith Alissa Hahn$18,972,390
- Harriet Mayanja-Kizza$3,524,628
- Nola M. Hylton$19,153,972
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisDesignProgramsResearch PersonnelRegimenTuberculosis TreatmentPharmaceutical PreparationsFundingSiteLaboratoriesMycobacterium TuberculosisNational Institute Of Allergy And Infectious DiseaseInnovationCharacteristicsNext GenerationPersonsClinical TrialsCostTechnologyAwardClinical ResearchStructureEvaluationCollaborations
Grant awards (54)
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$2,408,741
R01 · FY2025 · AI · contact PI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$1,157,460
U01 · FY2025 · AI · contact PI
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)$968,419
P30 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$648,576
R01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$455,914
R01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$433,790
R01 · FY2025 · AI · contact PI
Tuberculosis Research and Mentorship Program (TB RAMP II)$379,080
R25 · FY2025 · AI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$323,255
R01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$225,051
R01 · FY2025 · AI · contact PI
UCSF-UCB TRAC ADMININSTRATIVE CORE$222,903
P30 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$216,001
R01 · FY2025 · AI · contact PI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$184,085
U01 · FY2025 · AI · contact PI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$92,645
U01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)$49,256
R01 · FY2025 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,929,838
U01 · FY2024 · AI · contact PI
C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study$2,655,299
U01 · FY2024 · AI · contact PI
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)$968,441
P30 · FY2024 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$350,998
R25 · FY2024 · AI
UCSF-UCB TRAC ADMININSTRATIVE CORE$320,661
P30 · FY2024 · AI · contact PI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$1,350,629
U01 · FY2023 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$1,016,488
U01 · FY2023 · AI · contact PI
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)$968,462
P30 · FY2023 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$351,000
R25 · FY2023 · AI
UCSF-UCB TRAC ADMININSTRATIVE CORE$283,339
P30 · FY2023 · AI · contact PI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,977,411
U01 · FY2022 · AI · contact PI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$1,342,487
U01 · FY2022 · AI · contact PI
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)$968,482
P30 · FY2022 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$887,447
R01 · FY2022 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$351,000
R25 · FY2022 · AI
UCSF-UCB TRAC ADMININSTRATIVE CORE$274,477
P30 · FY2022 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$270,000
R25 · FY2022 · AI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,996,362
U01 · FY2021 · AI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$1,357,160
U01 · FY2021 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$351,000
R25 · FY2021 · AI
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)$3,774,253
U01 · FY2020 · AI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial$1,470,699
U01 · FY2020 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$1,418,814
R01 · FY2020 · AI · contact PI
TB Research And Mentorship Program (TB RAMP)$350,997
R25 · FY2020 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$1,468,225
R01 · FY2019 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$1,258,441
R01 · FY2018 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$50,210
R01 · FY2018 · AI · contact PI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31$1,143,898
R01 · FY2017 · AI · contact PI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)$1,142,366
R01 · FY2017 · AI · contact PI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)$1,146,372
R01 · FY2016 · AI · contact PI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)$1,154,896
R01 · FY2015 · AI · contact PI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)$1,167,864
R01 · FY2014 · AI · contact PI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)$1,543,781
R01 · FY2013 · AI · contact PI
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis$295,965
R43 · FY2013 · AI
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis$296,056
R43 · FY2012 · AI
Interplay of strain and ethnicity in the immune response to M. tuberculosis$125,820
K23 · FY2011 · HL · contact PI
Interplay of strain and ethnicity in the immune response to M. tuberculosis$125,820
K23 · FY2010 · HL · contact PI
Interplay of strain and ethnicity in the immune response to M. tuberculosis$125,820
K23 · FY2009 · HL · contact PI
Interplay of strain and ethnicity in the immune response to M. tuberculosis$124,200
K23 · FY2008 · HL · contact PI
Interplay of strain and ethnicity in the immune response to M. tuberculosis$124,200
K23 · FY2007 · HL · contact PI